These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11716158

  • 1. Endocrine complications of thalassemia.
    Tiosano D, Hochberg Z.
    J Endocrinol Invest; 2001 Oct; 24(9):716-23. PubMed ID: 11716158
    [Abstract] [Full Text] [Related]

  • 2. Endocrine complications in patients with Thalassaemia Major.
    Toumba M, Sergis A, Kanaris C, Skordis N.
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [Abstract] [Full Text] [Related]

  • 3. [Severe chronic anemia and endocrine disorders in children].
    Hauschild M, Theintz G.
    Rev Med Suisse; 2007 Apr 18; 3(107):988-91. PubMed ID: 17526372
    [Abstract] [Full Text] [Related]

  • 4. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
    Kattamis CA, Kattamis AC.
    Semin Hematol; 1995 Oct 18; 32(4):269-79. PubMed ID: 8560284
    [No Abstract] [Full Text] [Related]

  • 5. Advances in the recognition and treatment of endocrine complications in children with chronic illness.
    Zeitler PS, Travers S, Kappy MS.
    Adv Pediatr; 1999 Oct 18; 46():101-49. PubMed ID: 10645463
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia.
    Pediatr Endocrinol Rev; 2004 Dec 18; 2 Suppl 2():249-55. PubMed ID: 16462705
    [Abstract] [Full Text] [Related]

  • 7. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M, Citarella S, Filosa A, De Michele E, Palmieri F, Ragozzino A, Amendola G, Pugliese U, Tartaglione I, Della Rocca F, Cinque P, Nobili B, Perrotta S.
    Am J Hematol; 2014 Dec 18; 89(12):1102-6. PubMed ID: 25197009
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.
    Merchant RH, Shirodkar A, Ahmed J.
    Indian J Pediatr; 2011 Jun 18; 78(6):679-83. PubMed ID: 21234716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children.
    Högler W, Baumann U, Kelly D.
    J Pediatr Gastroenterol Nutr; 2012 Mar 18; 54(3):313-21. PubMed ID: 22064631
    [Abstract] [Full Text] [Related]

  • 13. [Endocrine disorders in diabetes mellitus].
    Okazaki R, Toriumi M, Tanaka K.
    Nihon Rinsho; 1997 Oct 18; 55 Suppl():667-72. PubMed ID: 9392179
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Growth and endocrine function in major thalassemia].
    Pérignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R.
    Arch Fr Pediatr; 1993 Oct 18; 50(8):657-63. PubMed ID: 8002739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.